From June 26 to 27, 2022, the Company accepted and passed the drug manufacturing certificate inspection on Recombinant Staphylococcus Aureus Vaccine (RSAV) by the inspection team organized by Sichuan Center for Food and Drug Evaluation, Inspection & Monitoring.

The inspection is detailed in the following table. Besides, no penalties were made against the Company's products due to quality since their launch.